Bluemonte大型价值主动型ETF BVAL 深 沪
交易中 05-20 10:27:09 美东时间
30.225
+0.085
+0.28%
华盛通- 最 高30.225
- 今 开30.14
- 成交量 2773股
- 最 低 30.225
- 昨 收 30.14
- 总市值 2.53亿
- 52周最高 30.48
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 15.8441
- 委 比 5.88%
- 总股本 837.30万
- 历史最高 30.48
- 量 比 0.80
- 振 幅 0.00%
- 历史最低 11.1091
- 每 手 1
- 风险率 1.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Atara Plans FDA Type A Meeting on EBVALLO
The latest update is out from Atara Biotherapeutics ( ($ATRA) ). On March 12, 2...
03-12 20:37
Atara, Pierre Fabre seek FDA meeting on EBVALLO
Atara Biotherapeutics ( ($ATRA) ) just unveiled an announcement. On March 3, 20...
03-03 21:57
Atara Biotherapeutics Resubmits Tabelecleucel BLA to FDA, Awaits Regulatory Review Following Manufacturing Collaboration with Pierre Fabre Pharmaceuticals
Atara Biotherapeutics Inc. has resubmitted the Biologics License Application (BLA) for tabelecleucel to the U.S. Food and Drug Administration on July 11, 2025, following a rapid response to observatio...
2025-07-15 20:02
BUZZ-Atara Biotherapeutics rises after direct stock offering, business update
** Shares of Atara Biotherapeutics ATRA.O up 7% premarket to $7.07 after co announces equity raise and business update ** Thousand Oaks, California-based firm announces pricing ~2.4 mln shares, includ...
2025-05-15 21:25
Atara Biotherapeutics Inc. Resumes Clinical Trials for EBVALLO™ After FDA Lifts Hold
Atara Biotherapeutics Inc. has announced a significant regulatory update regarding its EBVALLO™ (tabelecleucel) program. The U.S. Food and Drug Administration (FDA) has lifted the clinical hold on Ata...
2025-05-06 05:09
BRIEF-Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLOTM (tabelecleucel)
Jan 16 (Reuters) - Atara Biotherapeutics Inc ATRA.O: ATARA BIOTHERAPEUTICS PROVIDES REGULATORY AND BUSINESS UPDATE ON EBVALLOTM (TABELECLEUCEL) ATARA BIOTHERAPEUTICS INC: RECEIVED FDA COMPLETE RESPONS...
2025-01-16 21:36
